Pediatric Urinary Tract Infection Management

Urinary tract infections (UTIs) rank among the most common bacterial illnesses in children, with peak incidence in infancy and early childhood. Clinical presentation often centres on fever without a clear source, especially in non‐toilet‐trained infants, making prompt and accurate diagnosis essential to prevent renal injury. Management comprises three interlinked components: diagnostic evaluation, acute treatment and prevention of recurrence. Diagnosis balances non‐invasive sample collection methods against the need to detect underlying anatomical anomalies; risk factors such as non‐Escherichia coli pathogens, high‐grade fever and abnormal ultrasound findings guide selective use of voiding cystourethrography to identify vesicoureteral reflux or congenital anomalies. Acute therapy involves empirical antibiotic selection based on local resistance patterns, followed by adjustment once culture and sensitivity data are available. Preventive strategies focus on judicious antibiotic prophylaxis in high‐risk children, bladder–bowel management and consideration of dietary or behavioural adjuncts to reduce recurrence. Long‐term follow‐up includes monitoring of renal growth and function, with imaging reserved for those with recurrent or complicated infections. Recent innovation aims to refine diagnostic accuracy and reduce antibiotic overuse through biomarker discovery and data‐driven predictive models, reflecting a shift towards personalised, risk‐based care that minimises invasive procedures and safeguards renal health.

Research from Nature Portfolio

Recent work has applied machine learning to merge clinical signs and urinary immunological markers, enhancing diagnostic precision for paediatric UTI. By assessing simple clinical features—most notably graded urine turbidity—alongside biomarkers such as MMP9, NGAL, CXCL8 and IL-1β, predictive algorithms achieved superior rule-in and rule-out metrics compared with conventional culture thresholds. These models hold promise for rapid point-of-care tests that could curtail empirical antibiotic prescribing and mitigate the rise of antimicrobial resistance.

Pediatric Urinary Tract Infection Management publication trend

The graph below shows the total number of articles in pediatric urinary tract infection management across all publications each year (not limited to Nature Index journals).

Technical terms

Pyelonephritis: Infection of the renal pelvis and kidney parenchyma.

Vesicoureteral reflux (VUR): Retrograde flow of urine from the bladder into the ureters and kidneys.

Renal scarring: Permanent loss of functional kidney tissue following infection or reflux.

Antibiotic prophylaxis: Preventive administration of low‐dose antibiotics to reduce recurrent UTI.

Biomarker: Measurable molecule that indicates the presence or severity of disease.

Antimicrobial resistance: Reduced susceptibility of pathogens to standard antibiotic therapies.

References

1. Update of the EAU/ESPU guidelines on urinary tract infections in children. Journal of Pediatric Urology (2021).
2. Swiss consensus recommendations on urinary tract infections in children. European Journal of Pediatrics (2020).
3. Management of Vesicoureteral Reflux: What Have We Learned Over the Last 20 Years?. Frontiers in Pediatrics (2021).
4. Identification of clinical and urine biomarkers for uncomplicated urinary tract infection using machine learning algorithms. Scientific Reports (2019).